Last updated: 11/03/2018 13:24:02

Study of natural history of human papillomavirus (HPV) infections in adult women with recurrent conizations in Norway

GSK study ID
112674
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Discontinued
Discontinued
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A retrospective epidemiological study of natural history of HPV infections in women aged 18 years and above with recurrent conization following a primary conization for high grade lesions/ microinvasive cervical carcinomas, in Norway
Trial description: This is a register-based, epidemiological study of HPV type distribution in women aged 18 years and above with recurrent conization following a primary conization for high grade lesions/ microinvasive carcinomas. This study will involve data collection from different databases in the Cancer Registry of Norway.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

HPV-types as single group considered as new infections in recurrent conizations with high grade lesions, microinvasive cervical carcinomas or ICC diagnosis.

Timeframe: At the end of the study.

HPV-types as single group considered as persistent infections in recurrent conizations with high grade lesions, microinvasive cervical carcinomas or ICC diagnosis.

Timeframe: At the end of the study.

Secondary outcomes:

HPV-types as individual types or as different groups considered as new infections in recurrent conizations presenting high grade lesions, microinvasive cervical carcinomas or ICC diagnosis.

Timeframe: At the end of the study.

HPV-types as individual types or as different groups considered as persistent infections in recurrent conizations presenting high grade lesions, microinvasive cervical carcinomas or ICC diagnosis.

Timeframe: At the end of the study.

Interventions:
Procedure/surgery: Cancer Registry of Norway (database)
Enrollment:
410
Observational study model:
Case-Only
Primary completion date:
Not applicable
Time perspective:
Retrospective
Clinical publications:
Not applicable
Medical condition
Infections, Papillomavirus
Product
SB580299
Collaborators
Not applicable
Study date(s)
June 2010 to August 2010
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Female
Age
18+ years
Accepts healthy volunteers
No
  • All subjects must meet the following criteria at study entry:
  • Women aged 18 years and above at the time of the collection of the primary cone specimen;
  • None.

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
Bergen, Norway, 5053
Status
Study Complete

Study documents

No study documents available.

Results overview

No study documents available

Recruitment status
Discontinued
Actual primary completion date
Not applicable
Actual study completion date
2010-20-08

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website